Pharmaceutical firm ScieGen is expanding its manufacturing
operations on Long Island and adding over 100 jobs.
The $15 million expansion will help ScieGen, a subsidiary of
Bactolac Pharmaceutical, bolster its production of prescription drugs to meet growing
demands.
The company plans to convert 65,000 s/f of former warehouse
space at its facility at 33 Oser Avenue in Hauppauge into manufacturing space
with washrooms, an office, labs and a cafeteria.
And it will use Long Island-based vendors to make the space
FDA compliant.
“We’re excited to continue to grow on Long Island and
develop a much-needed production space for pharmaceutical manufacturing,” said
Bactolac Pharmaceutical Inc.’s, Chief Financial Officer Renee Reynolds. “The
Suffolk IDA continues to be an active partner in our growth, and their
assistance will greatly help us continue to employ hundreds of Long Islanders
and produce essential medications.”
Suffolk County Industrial Development Agency (IDA) has
preliminarily approved a transaction to assist ScieGen convert and renovate the
Oser Avenue space/. The IDA has supported the pharma firm since it first opened
in Hauppauge in 2009, producing generic prescription drugs and medications. The
company has expanded to multiple locations since. Parent company Bactolac,
which makes vitamins and dietary supplements, was established in 1995 and has
grown from a single, 5,000 s/f facility in Westbury to multiple facilities
across Long Island.
The two companies combine for over 700 employees and generated dozens of jobs bringing their facilities up to code and FDA-compliant. In the last three years alone, they have expended over $121 million to local vendors and contractors and they aim to utilize Long Island-based vendors and contractors throughout this latest project.
“At a time when so many are losing their jobs and businesses are struggling to keep the doors open, we are fortunate to have a solid company, rooted right here in Suffolk County, ready to make a sizable investment that will create more than 100 jobs,” said Tony Catapano, Executive Director of the Suffolk County IDA.
“During the height of a public health and economic crisis, the Suffolk IDA is pleased to assist ScieGen expand their capacity for manufacturing pharmaceuticals while also creating opportunities for our residents.”
“A continued partnership with ScieGen is a win for Long
Island and its pharmaceutical manufacturing industry, especially during these
incredibly challenging times,” said Kelly Morris, Deputy Executive Director of
the Suffolk County IDA. “The companies employ hundreds of Long Island residents
and provide millions in tax revenue for the region and we are proud that they
call Suffolk County home.”
